Publikationen in Zusammenarbeit mit Forschern von Fundación Jiménez Díaz (59)

2014

  1. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

2004

  1. Virus-Specific Effector CD4+ T-Cell Responses in Hemodialysis Patients with Hepatitis C Virus Infection

    Journal of Medical Virology, Vol. 72, Núm. 1, pp. 66-74

2002

  1. Features of the CD4+ t-cell response in liver and peripheral blood of hepatitis C virus-infected patients with persistently normal and abnormal alanine aminotransferase levels

    Journal of Hepatology, Vol. 36, Núm. 3, pp. 408-416

2001

  1. Expression of factor VII in the liver of patients with liver disease: Correlations with the disease severity and impairment in the hemostasis

    Blood Coagulation and Fibrinolysis, Vol. 12, Núm. 3, pp. 193-199

2000

  1. Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: Evaluation of the bleeding risk

    Blood Coagulation and Fibrinolysis

  2. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients

    Hepatology, Vol. 31, Núm. 2, pp. 502-506

  3. Randoimized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis C

    Cytokine, Vol. 12, Núm. 2, pp. 165-170

  4. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease

    Cytokine, Vol. 12, Núm. 8, pp. 1248-1252

1999

  1. Cinetica del interferon α-2a en pacientes en hemodialisis

    Nefrologia, Vol. 19, Núm. 3, pp. 268-270

  2. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus

    Journal of Infectious Diseases, Vol. 180, Núm. 2, pp. 262-267

  3. Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells

    Cytokine, Vol. 11, Núm. 4, pp. 267-273

  4. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a

    Hepatology, Vol. 30, Núm. 1, pp. 277-282

1998

  1. Effects of the ribavirin-interferon α combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients

    Cytokine, Vol. 10, Núm. 8, pp. 635-644

  2. Induction of interleukin-12 production in chronic hepatitis C virus infection correlate with the hepatocellular damage

    Journal of Infectious Diseases, Vol. 178, Núm. 1, pp. 247-251

1997

  1. Biological properties of interleukin-12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection.

    Journal of viral hepatitis, Vol. 4 Suppl 2, pp. 83-86

  2. Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay

    Journal of Clinical Microbiology, Vol. 35, Núm. 1, pp. 317-321

  3. Impaired interferon induction of human MxA protein in C chronic hepatitis B virus infection

    Journal of Medical Virology, Vol. 51, Núm. 4, pp. 332-337

  4. Multicenter randomized, controlled study of intramuscular administration of interferon-β for the treatment of chronic hepatitis C

    Journal of Interferon and Cytokine Research, Vol. 17, Núm. 1, pp. 27-30

  5. Tolerance and efficacy of subcutaneous interferon-β administered for treatment of chronic hepatitis C

    Journal of Interferon and Cytokine Research, Vol. 17, Núm. 2, pp. 65-67

1996

  1. Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon α treatment of chronic hepatitis C

    Cytokine, Vol. 8, Núm. 4, pp. 318-322